Cancer Immunotherapy News and Research

RSS
CEL-SCI gets approval to start enrollment for Multikine Phase III study for head and neck cancer

CEL-SCI gets approval to start enrollment for Multikine Phase III study for head and neck cancer

5 Dec 2013
Researchers find correlation between biomarker and patient’s ability to respond to Imprime PGG

Researchers find correlation between biomarker and patient’s ability to respond to Imprime PGG

5 Dec 2013
Top cancer research centers to establish new biotechnology company focused on cancer immunotherapy

Top cancer research centers to establish new biotechnology company focused on cancer immunotherapy

4 Dec 2013
Immune Design closes Series C financing totalling up to $49M

Immune Design closes Series C financing totalling up to $49M

30 Oct 2013
Imugene Acquiring Biolife, As Lead Pipeline Candidate Nears Phase II

Imugene Acquiring Biolife, As Lead Pipeline Candidate Nears Phase II

23 Oct 2013
FDA grants orphan drug designation to Aduro's CRS-207 for treatment of pancreatic cancer

FDA grants orphan drug designation to Aduro's CRS-207 for treatment of pancreatic cancer

22 Oct 2013
Genalyte Gets Grant From NCI To Develop Biomarker Panel For Cancer

Genalyte Gets Grant From NCI To Develop Biomarker Panel For Cancer

18 Oct 2013
Genalyte receives NCI grant to develop biomarker panel to profile TAA autoantibodies

Genalyte receives NCI grant to develop biomarker panel to profile TAA autoantibodies

18 Oct 2013
immatics biotechnologies closes €34 million Series D financing round

immatics biotechnologies closes €34 million Series D financing round

15 Oct 2013
New gene transfer strategy effective for achieving persistent immunotherapy to treat tumors

New gene transfer strategy effective for achieving persistent immunotherapy to treat tumors

11 Oct 2013
SBIR Awards Etubics $1.5M To Manufacture Breast Cancer Immunotherapy

SBIR Awards Etubics $1.5M To Manufacture Breast Cancer Immunotherapy

27 Sep 2013
LSDF announces Proof of Concept grants to speed up promising health-related technologies

LSDF announces Proof of Concept grants to speed up promising health-related technologies

18 Sep 2013
Bayer, Broad On Five-Year Mission To Search For Novel Cancer Therapeutics

Bayer, Broad On Five-Year Mission To Search For Novel Cancer Therapeutics

10 Sep 2013
Roche Signs Up To $422.5M Collaboration With Inovio

Roche Signs Up To $422.5M Collaboration With Inovio

10 Sep 2013
Roche, Inovio Pharmaceuticals to develop DNA-based vaccines for prostate cancer and hepatitis B

Roche, Inovio Pharmaceuticals to develop DNA-based vaccines for prostate cancer and hepatitis B

10 Sep 2013
Novel Approach Developed On Antitumor Immunotherapy

Novel Approach Developed On Antitumor Immunotherapy

22 Aug 2013
New type of cancer immunotherapy harnesses body's immune system to attack tumors

New type of cancer immunotherapy harnesses body's immune system to attack tumors

19 Aug 2013
Compugen, Bayer sign collaboration and license agreement for antibody-based cancer immunotherapies

Compugen, Bayer sign collaboration and license agreement for antibody-based cancer immunotherapies

5 Aug 2013
Using the immune system to control cancer: an interview with Dr. Jedd Wolchok, MD, PhD, Ludwig Center at MSKCC

Using the immune system to control cancer: an interview with Dr. Jedd Wolchok, MD, PhD, Ludwig Center at MSKCC

1 Aug 2013
ImmunoCellular initiates ICT-121 phase I trial in patients with recurrent glioblastoma multiforme

ImmunoCellular initiates ICT-121 phase I trial in patients with recurrent glioblastoma multiforme

30 Jul 2013

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback